The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2020

Filed:

Aug. 09, 2016
Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

Xiaotian Zhong, Wayland, MA (US);

Amarnauth Shastrie Prashad, New City, NY (US);

Ronald William Kriz, Northborough, MA (US);

Tao He, Acton, MA (US);

Will Somers, Lexington, MA (US);

Wenge Wang, Andover, MA (US);

Leo Joseph Letendre, Oakdale, CT (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); C07K 16/00 (2006.01); C07K 16/30 (2006.01); A61K 38/05 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6889 (2017.08); A61K 38/05 (2013.01); A61K 47/68 (2017.08); A61K 47/6817 (2017.08); A61K 47/6851 (2017.08); A61K 47/6855 (2017.08); C07K 16/00 (2013.01); C07K 16/30 (2013.01); C07K 2317/14 (2013.01); C07K 2317/40 (2013.01); C07K 2317/526 (2013.01); C07K 2317/55 (2013.01); C07K 2317/94 (2013.01);
Abstract

An antibody production process in mammalian cells in which engineered unpaired cysteine residues are post-translationally modified and capped with particular chemical entities, which capped antibodies are well suited to further site-specific conjugation steps to form antibody-drug conjugates (ADCs) or protein drug conjugates; ADCs produced using these capped antibodies including in particular ADCs formed by the selective reduction of the capped antibodies' cysteine residues, and ADCs formed using chemical handles such as aldehyde/azide/alkyne biorthogonal groups, which permit additional drug conjugation chemistry; and uncapped antibodies produced by cells in low cysteine, cysteine and glutathione media, and ADCs produced via direct conjugation to these uncapped antibodies.


Find Patent Forward Citations

Loading…